- Heparegenix completes first darizmetinib treatment in phase 1b
- Ethiopia, Norway and UK boost global epidemic preparedness
- AstronauTx receives funding for Parkinson’s sleep research
- Roche welcomes MHRA approval of Gazyvaro
- Grünenthal acquires cancer medicine Stivarga
- CHMP backs expanded use of teclistamab
- Axoltis reports positive phase 2 data for NX210c
- Sanofi and Cheplapharm forge new medicines partnership
- Japan approves prefilled syringe for GSK’s shingles vaccine
- EpilepsyGTx and Viralgen partner to scale AAV manufacturing for EPY201
- Zerion partner files first EU application for Dispersome‑enabled product
- Tozorakimab shows broad COPD benefit in new phase 3 data
- Study highlights advance in influenza protection for older adults
- NICE backs daratumumab quadruplet for transplant‑eligible myeloma
- Teitur reports positive early data for Parkinson’s peptide TT‑P34
- Amivantamab regimen delivers longest survival in EGFR Ex20ins lung cancer
- NICE backs ibrutinib regimen for untreated mantle cell lymphoma
- Livdelzi accepted in Scotland for treatment of PBC
- FDA approves Tivicay pd for youngest HIV patients
- Koala trial doses first patient with novel KMA‑targeting CAR‑T
Website: https://www.pharmatimes.com
